TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats
Background: Current diabetes therapies often fail to address the loss of insulin-producing β-cells. Bone marrow mesenchymal stem cells (BMSCs) can differentiate into insulin-producing cells (IPCs), but functional maturity remains limited. Toll-like receptor 9 (TLR9) agonists may enhance BMSC maturat...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
University of Karachi
2026-01-01
|
| Collection: | Pakistan Journal of Pharmaceutical Sciences |
| Accès en ligne: | https://pjps.pk/single-article?id=cmr8j09b1007k85f4lfu448r9 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|